Glycosylation of sputum mucins is altered in cystic fibrosis patients

By Schulz Benjamin L   Sloane Andrew J   Robinson Leanne J   Prasad Sindhu S   Lindner Robyn A   Robinson Michael   Bye Peter T   Nielson Dennis W   Harry Jenny L   Packer Nicolle H   Karlsson Niclas G  

Glycobiology, Vol. 17, Iss. 7, 2007-07 ,pp. : 698-712

Oxford University Press

Access to resources Recommend Favorite

Serum Zinc Concentrations in Cystic Fibrosis Patients Aged Above 4 Years: A Cross-sectional Evaluation

By Biervliet S.   Biervliet J.   Velde S.   Robberecht E.  

Biological Trace Element Research, Vol. 119, Iss. 1, 2007-10 ,pp. : 19-26

Humana Press, Inc

Access to resources Recommend Favorite

First report of cystic fibrosis mutations in Libyan cystic fibrosis patients

By Hadj Fredj Sondess   Fattoum Slaheddine   Chabchoub Abdelraouf   Messaoud Taieb  

Annals of Human Biology, Vol. 38, Iss. 5, 2011-09 ,pp. : 561-563

Informa Healthcare

Access to resources Recommend Favorite

Design and evaluation of a peptide‐based immunotoxin for breast cancer therapeutics

By  

FEBS Open Bio, Vol. 5, Iss. 1, 2015-01 ,pp. : 202-208

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antioxidant binding of caeruloplasmin to myeloperoxidase: Myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact

By Park Y.S.   Suzuki K.   Mumby Sharon   Taniguchi N.   Gutteridge John  

Free Radical Research, Vol. 33, Iss. 3, 2000-01 ,pp. : 261-265

Informa Healthcare

Access to resources Recommend Favorite